Vault-13

NEWAMSTERDAM PHARMA COMPANY NAMSW

*W EXP 11/22/202 · Equity WRT · CUSIP N62509117

11 institutional holders +0 vs Q1 2025
1,303,8351.3m shares reported held*
$10.4mreported value*
0 new 2 added 2 reduced 0 sold out net sold ≈ $49.4k (-3.1k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.00. Options: 1 managers hold calls ($600.0k notional), 0 hold puts (—).

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

0102030Q4 22: 23Q1 23: 20Q2 23: 20Q3 23: 20Q4 23: 19Q1 24: 12Q2 24: 11Q3 24: 12Q4 24: 12Q1 25: 11Q2 25: 1111Q4 22Q2 23Q4 23Q2 24Q4 24Q2 25
Numbers
QuarterHolders
Q4 202223
Q1 202320
Q2 202320
Q3 202320
Q4 202319
Q1 202412
Q2 202411
Q3 202412
Q4 202412
Q1 202511
Q2 202511

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q3 23: 2 bought or addedQ3 23: 5 cut or sold outQ4 23: 1 bought or addedQ4 23: 4 cut or sold outQ4 23Q1 24: 4 bought or addedQ1 24: 10 cut or sold outQ2 24: 1 bought or addedQ2 24: 2 cut or sold outQ2 24Q3 24: 2 bought or addedQ3 24: 2 cut or sold outQ4 24: 3 bought or addedQ4 24: 3 cut or sold outQ4 24Q1 25: 1 bought or addedQ1 25: 3 cut or sold outQ2 25: 2 bought or addedQ2 25: 2 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q3 202325
Q4 202314
Q1 2024410
Q2 202412
Q3 202422
Q4 202433
Q1 202513
Q2 202522

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$500k$1m$1.5mQ3 24 calls: $525.0kQ3 24 puts: $0Q3 24P/C 0.00Q4 24 calls: $1.1mQ4 24 puts: $0Q4 24P/C 0.00Q1 25 calls: $674.2kQ1 25 puts: $0Q1 25P/C 0.00Q2 25 calls: $600.0kQ2 25 puts: $0Q2 25P/C 0.00
Numbers
QuarterCallsPutsP/C
Q3 2024$525.0k$00.00
Q4 2024$1.1m$00.00
Q1 2025$674.2k$00.00
Q2 2025$600.0k$00.00

Biggest buyers

Affinity Asset Advisors, LLC Added +3,043+3.0k
CIBC Private Wealth Group LLC Added +2,000+2.0k

Biggest sellers

WOLVERINE ASSET MANAGEMENT LLC Reduced -6,793-6.8k
UBS Group AG Reduced -1,388-1.4k

Biggest calls

MILLENNIUM MANAGEMENT LLC Unchanged $600.0k75.0k shares

Biggest puts

None

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Insider purchases and sales in Q2 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
404Q3 23: 0 buyingQ3 23: 0 sellingQ4 23: 0 buyingQ4 23: 0 sellingQ4 23Q1 24: 2 buyingQ1 24: 1 sellingQ2 24: 1 buyingQ2 24: 0 sellingQ2 24Q3 24: 2 buyingQ3 24: 0 sellingQ4 24: 0 buyingQ4 24: 1 sellingQ4 24Q1 25: 1 buyingQ1 25: 4 sellingQ2 25: 1 buyingQ2 25: 1 sellingQ2 25
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20230—0——
Q4 20230—0——
Q1 20242$276.2k1$4.1m—
Q2 20241$86.3k0——
Q3 20242$98.7k0——
Q4 20240—1$707.4k—
Q1 20251$109.7k4$3.1m—
Q2 20251$236.8k1$1.9m$1.9m
DateInsiderTradeSharesPrice ValueTheir holding
2025-06-25 Topper James N Director · By Frazier Life Sciences X, L.P. Bought 1,260 $18.26 $23.0k1.3k shares +<1%
2025-06-24 Topper James N Director · By Frazier Life Sciences X, L.P. Bought 2,520 $18.43 $46.4k2.5k shares +<1%
2025-06-16 Kling Douglas F Chief Operating Officer Sold plan 100,000 $19.29 $1.9m100.0k shares -69%
2025-06-16 Topper James N Director · By Frazier Life Sciences X, L.P. Bought 8,584 $19.50 $167.4k8.6k shares +<1%
2025-05-15 Kling Douglas F Chief Operating Officer Sold plan 100,000 — —100.0k shares -69%
2025-04-15 Kling Douglas F Chief Operating Officer Sold plan 100,000 — —100.0k shares -69%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Frazier Life Sciences Management, L.P. 0.16% of their portfolio PALO ALTO, CA 500,333500.3k $4.0m $4.0m 0.16% Unchanged
2 RA CAPITAL MANAGEMENT, L.P. 0.04% of their portfolio BOSTON, MA 333,333333.3k $2.7m $2.7m 0.04% Unchanged
3 Affinity Asset Advisors, LLC 0.29% of their portfolio NEW YORK, NY 245,000245.0k $2.0m $2.0m 0.29% Added +3.0k +3,043
4 Bain Capital Life Sciences Investors, LLC 0.10% of their portfolio Boston, MA 100,000100.0k $800.0k $800.0k 0.10% Unchanged
5 DEERFIELD MANAGEMENT COMPANY, L.P. 0.01% of their portfolio New York, NY 92,78792.8k $742.3k $742.3k 0.01% Unchanged
6 Laurion Capital Management LP 0.02% of their portfolio NEW YORK, NY 16,66616.7k $133.3k $133.3k 0.02% Unchanged
7 Vestcor Inc 0.00% of their portfolio FREDERICTON, A3 9,6329.6k $77.0k $77.0k 0.00% Unchanged
8 CIBC Private Wealth Group LLC 0.00% of their portfolio ATLANTA, GA 3,0003.0k $24.2k $24.2k 0.00% Added +2.0k +2,000
9 WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio CHICAGO, IL 2,0912.1k $16.7k $16.7k 0.00% Reduced -6.8k -6,793
10 UBS Group AG 0.00% of their portfolio ZURICH, V8 993993 $7.9k $7.9k 0.00% Reduced -1.4k -1,388
11 CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio BIRMINGHAM, AL 00 $0 $0 — Unchanged